CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis

Objective. To investigate whether single nucleotide polymorphisms (SNPs) within cytotoxic T-lymphocyte antigen-4 (CTLA-4) are associated with ANCA-associated small vessel vasculitis (SVV). Methods. The CTLA-4 CT60 (exon 4), +49 (exon 1) and −318 (promoter region) genotypes were determined by PCR and...

Full description

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 48; no. 12; pp. 1502 - 1505
Main Authors Kamesh, Lavanya, Heward, Joanne M., Williams, Julie M., Gough, Stephen C. L., Chavele, Konstantia-Maria, Salama, Alan, Pusey, Charles, Savage, Caroline O. S., Harper, Lorraine
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.12.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective. To investigate whether single nucleotide polymorphisms (SNPs) within cytotoxic T-lymphocyte antigen-4 (CTLA-4) are associated with ANCA-associated small vessel vasculitis (SVV). Methods. The CTLA-4 CT60 (exon 4), +49 (exon 1) and −318 (promoter region) genotypes were determined by PCR and restriction fragment length polymorphism (RFLP) in 222 white Caucasians of UK origin with SVV and 670 ethnically matched controls. Results. The CTLA-4 exon 1 (+49) and 4 (CT60) polymorphisms are associated with SVV (+49: χ2 = 10.965, P = 0.004; CT60: χ2 = 12.017, P = 0.002). Both disease-susceptible and disease-protective haplotypes have been identified in this cohort, and their frequencies are similar in the subtypes of WG and microscopic polyangiitis. Conclusion. This study provides further evidence that CTLA-4, a susceptibility locus for a number of common autoimmune diseases, may also be involved in the development of ANCA-associated SVV.
Bibliography:istex:352A7ABB55CAC719FD6870DF548D0A22A5C70658
ArticleID:kep280
ark:/67375/HXZ-K0RNTRKH-L
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1462-0324
1462-0332
1462-0332
DOI:10.1093/rheumatology/kep280